Skip to main content

Advertisement

Log in

Predictors of persistent pulmonary hypertension after mitral valve replacement

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Persistent pulmonary hypertension (P-PH) after mitral valve replacement (MVR) leads to an increased risk of morbidity and mortality. We sought to determine which factors were involved in its occurrence. Patients undergoing MVR for a 3-year period were collected in a retrospective way. We excluded those with an available follow-up shorter than 3 months. Sample size was 111 patients. PH was diagnosed if systolic pulmonary artery pressure (sPAP) estimated by Doppler echocardiography was >40 mmHg. Clinical, echocardiographic, and surgical factors were analyzed. P-PH was present in 42.3 % of patients after 12.6 months of mean follow-up. P-PH was more frequently observed in elderly and female patients, in those with severe degrees of PH before surgery, and significant tricuspid regurgitation (TR). On multivariable analysis, significant TR (OR 1.739; p = 0.01) and more severe degrees of PH before surgery (OR 1.761; p = 0.03) were significantly associated with the presence of P-PH after MVR. Surgical factors related to P-PH were prosthesis size and tricuspid annuloplasty: no need for the performing of tricuspid annuloplasty (OR 0.345; p = 0.025) and the implantation of a smaller prosthesis (OR 0.656; p = 0.004) were related to higher rates of P-PH after MVR. MVR was associated with high prevalence of P-PH after mid-term follow-up. Both PH and significant TR before surgery were associated with P-PH. Our data point out that MVR should be planned before the development of PH and greater TR. Smaller prosthetic size is also a risk factor for P-PH and bigger prostheses are desirable when possible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Vincens JJ, Temizer D, Post JR, Edmunds LH Jr, Herrmann HC (1995) Long-term outcome of cardiac surgery in patients with mitral stenosis and severe pulmonary hypertension. Circulation 92:II137–II142

    Article  CAS  PubMed  Google Scholar 

  2. Salomon NW, Stinson EB, Griepp RB, Shumway NE (1977) Mitral valve replacement: long-term evaluation of prosthesis-related mortality and morbidity. Circulation 56:II94–II101

    CAS  PubMed  Google Scholar 

  3. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M (2012) Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 33:2451–2496

    Article  PubMed  Google Scholar 

  4. Li M, Dumesnil JG, Mathieu P, Pibarot P (2005) Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol 45:1034–1040

    Article  PubMed  Google Scholar 

  5. Crawford FA (2005) Residual pulmonary artery hypertension after mitral valve replacement: size matters! J Am Coll Cardiol 45:1041–1042

    Article  PubMed  Google Scholar 

  6. Dev V, Shrivastava S (1991) Time course of changes in pulmonary vascular resistance and the mechanism of regression of pulmonary arterial hypertension after balloon mitral valvuloplasty. Am J Cardiol 67:439–442

    Article  CAS  PubMed  Google Scholar 

  7. Levine MJ, Weinstein JS, Diver DJ, Berman AD, Wyman RM, Cunningham MJ, Safian RD, Grossman W, McKay RG (1989) Progressive improvement in pulmonary vascular resistance after percutaneous mitral valvuloplasty. Circulation 79:1061–1067

    Article  CAS  PubMed  Google Scholar 

  8. Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno C, Lester SJ (2003) A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 41:1021–1027

    Article  PubMed  Google Scholar 

  9. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23:685–713

    Article  PubMed  Google Scholar 

  10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463

    Article  PubMed  Google Scholar 

  11. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, Badano L, Zamorano JL (2013) Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 14:611–644

    Article  PubMed  Google Scholar 

  12. Buckberg GD (1979) A proposed “solution” to the cardioplegic controversy. J Thorac Cardiovasc Surg 77:803–815

    CAS  PubMed  Google Scholar 

  13. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Jr Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS (2008) 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52:e1–142

    Article  PubMed  Google Scholar 

  14. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, Scott C, Schaff HV, Tajik AJ (2005) Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352:875–883

    Article  CAS  PubMed  Google Scholar 

  15. Tabata M, Kasegawa H, Suzuki T, Watanabe H, Fukui T, Takanashi S, Ono M (2013) Long-term outcomes of early surgery for asymptomatic severe chronic mitral regurgitation. J Heart Valve Dis 22:354–360

    PubMed  Google Scholar 

  16. Tribouilloy C, Grigioni F, Avierinos JF, Barbieri A, Rusinaru D, Szymanski C, Ferlito M, Tafanelli L, Bursi F, Trojette F, Branzi A, Habib G, Modena MG, Enriquez-Sarano M (2009) Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. J Am Coll Cardiol 54:1961–1968

    Article  PubMed  Google Scholar 

  17. Le Tourneau T, Richardson M, Juthier F, Modine T, Fayad G, Polge AS, Ennezat PV, Bauters C, Vincentelli A, Deklunder G (2010) Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart 96:1311–1317

    Article  PubMed  Google Scholar 

  18. Cruz-Gonzalez I, Semigram MJ, Inglessis-Azuaje I, Sanchez-Ledesma M, Martin-Moreiras J, Jneid H, Rengifo-Moreno P, Cubeddu RJ, Maree AO, Sanchez PL, Palacios IF (2013) Effect of elevated pulmonary vascular resistance on outcomes after percutaneous mitral valvuloplasty. Am J Cardiol 112:580–584

    Article  PubMed  Google Scholar 

  19. Tuzcu EM, Block PC, Griffin BP, Newell JB, Palacios IF (1992) Immediate and long-term outcome of percutaneous mitral valvotomy in patients 65 years and older. Circulation 85:963–971

    Article  CAS  PubMed  Google Scholar 

  20. Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block PC (2002) Which patients benefit from percutaneous mitral balloon valvuloplasty?: prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation 105:1465–1471

    Article  PubMed  Google Scholar 

  21. Angeloni E, Melina G, Benedetto U, Roscitano A, Refice S, Quarto C, Comito C, Pibarot P, Sinatra R (2013) Impact of prosthesis-patient mismatch on tricuspid valve regurgitation and pulmonary hypertension following mitral valve replacement. Int J Cardiol 168:4150–4154

    Article  PubMed  Google Scholar 

  22. Jamieson WR, Germann E, Ye J, Chan F, Cheung A, MacNab JS, Fradet GJ, Stanford EA, Bryson LA, Lichtenstein SV (2009) Effect of prosthesis-patient mismatch on long-term survival with mitral valve replacement: assessment to 15 years. Ann Thorac Surg 87:1135–1141

    Article  PubMed  Google Scholar 

  23. Ubago JL, Figueroa A, Ochoteco A, Colman T, Duran CG (1983) Analysis of the amount of tricuspid valve anular dilatation required to produce functional tricuspid regurgitation. Am J Cardiol 52:155–158

    Article  CAS  PubMed  Google Scholar 

  24. Sugimoto T, Okada M, Ozaki N, Hatakeyama T, Kawahira T (1999) Long-term evaluation of treatment for functional tricuspid regurgitation with regurgitant volume: characteristic differences based on primary cardiac lesion. J Thorac Cardiovasc Surg 117:463–471

    Article  CAS  PubMed  Google Scholar 

  25. Sagie A, Schwammenthal E, Padial LR, Vazquez de Prada J, Weyman E, Levine R (1994) Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: Doppler color flow study of 109 patients. J Am Coll Cardiol 24:446–453

    Article  CAS  PubMed  Google Scholar 

  26. Fukuda S, Song JM, Gillinov AM, McCarthy PM, Daimon M, Kongsaerepong V, Thomas JD, Shiota T (2005) Tricuspid valve tethering predicts residual tricuspid regurgitation after tricuspid annuloplasty. Circulation 111:975–979

    Article  PubMed  Google Scholar 

  27. Amano H, Toyoda S, Arikawa T, Inami S, Otani N, Nishi Y, Kitagawa Y, Taguchi I, Abe S, Inoue T (2013) Left ventricular function in pulmonary hypertension. Heart Vessel 28:505–509

    Article  Google Scholar 

  28. Kaneko H, Suzuki S, Uejima T, Kano H, Matsuno S, Otsuka T, Takai H, Oikawa Y, Yajima J, Koike A, Nagashima K, Kirigaya H, Sagara K, Tanabe H, Sawada H, Aizawa T, Yamashita T (2014) Prevalence and the long-term prognosis of functional mitral regurgitation in Japanese patients with symptomatic heart failure. Heart Vessel 29:801–807

    Article  Google Scholar 

  29. Lam BK, Chan V, Hendry P, Ruel M, Masters R, Bedard P, Goldstein B, Rubens F, Mesana T (2007) The impact of patient-prosthesis mismatch on late outcomes after mitral valve replacement. J Thorac Cardiovasc Surg 133:1464–1473

    Article  PubMed  Google Scholar 

  30. Ruel M, Rubens FD, Masters RG, Pipe AL, Bédard P, Mesana TG (2004) Late incidence and predictors of persistent or recurrent heart failure in patients with mitral prosthetic valves. J Thorac Cardiovasc Surg 128:278–283

    Article  PubMed  Google Scholar 

  31. Shiran A, Sagie A (2009) Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol 53:401–408

    Article  PubMed  Google Scholar 

  32. Ghoreishi M, Evans CF, DeFilippi CR, Hobbs G, Young CA, Griffith BP, Gammie JS (2011) Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg 142:1439–1452

    Article  PubMed  Google Scholar 

  33. Aoyagi S, Fukunaga S, Arinaga K, Tomoeda H, Akasu K, Ueda T (2010) Heart valve surgery in octogenarians: operative and long-term results. Heart Vessel 25:522–528

    Article  Google Scholar 

Download references

Conflict of interest

None of the authors declare any potential conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sem Briongos Figuero.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Briongos Figuero, S., Moya Mur, J.L., García-Lledó, A. et al. Predictors of persistent pulmonary hypertension after mitral valve replacement. Heart Vessels 31, 1091–1099 (2016). https://doi.org/10.1007/s00380-015-0700-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-015-0700-2

Keywords

Navigation